title: Bridging the Gap in Neurotherapeutic Discovery and Development: The Role of the National Institute of Neurological Disorders and Stroke in Translational Neuroscience.
abstract: The mission of the National Institute of Neurological Disorders and Stroke (NINDS) is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. NINDS supports early- and late-stage therapy development funding programs to accelerate preclinical discovery and the development of new therapeutic interventions for neurological disorders. The NINDS Office of Translational Research facilitates and funds the movement of discoveries from the laboratory to patients. Its grantees include academics, often with partnerships with the private sector, as well as small businesses, which, by Congressional mandate, receive > 3% of the NINDS budget for small business innovation research. This article provides an overview of NINDS-funded therapy development programs offered by the NINDS Office of Translational Research.
authors.affiliation: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, mottmc@od.nih.gov.
authors.forename: Meghan
authors.initials: M
authors.lastname: Mott
authors.forename: Walter
authors.initials: W
authors.lastname: Koroshetz
mesh_terms: D055808:Drug Discovery; D006801:Humans; D055825:National Institute of Neurological Disorders and Stroke (U.S.) / Q000639:trends*; D009422:Nervous System Diseases / Q000628:therapy*; D057170:Translational Research, Biomedical; D014481:United States